[Theoretical basis of the prevention of congenital toxoplasmosis in pregnant women by spiramycin].
D005260:Female; D006801:Humans; D007933:Leucomycins / Q000008:administration & dosage* / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D014125:Toxoplasmosis, Congenital / Q000517:prevention & control*
D007933:Leucomycins
Bases théoriques de la prévention de la toxoplasmose congéntilate chez la femme enceinte par la spiramycine.